A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19
Clinical trial NCT04425460 · UNKNOWN
Trial details
- NCT number
- NCT04425460
- Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-08-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.